Back to Top Skip to main content Skip to sub-navigation

Naval Air Facility El Centro administers COVID-19 vaccine

Military health personnel administering the COVID-19 vaccine Navy Hospitalman Gabriel Cabral, assigned to Naval Medical Center San Diego, from Maryland, administers first-round of Pfizer-BioNTech COVID-19 vaccine sailors and select Department of Defense support staff onboard Naval Air Facility EL Centro, California on March 4, 2021 (Photo by: Navy Petty Officer 3rd Class Drew Verbis, Navy Operational Support Center - Phoenix).

Recommended Content:

COVID-19 Considerations | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Sailors and select Department of Defense support staff began receiving the first-round of Pfizer-BioNTech COVID-19 vaccine onboard Naval Air Facility EL Centro in California, March 4, 2021.

Due to the emergency authorization the COVID-19 vaccine, while encouraged, remains voluntary for service members. The Department of Defense is taking a prioritized, phased approach for administering the vaccine to volunteer's, to strengthen the DOD's ability to protect personnel, maintain mission readiness, and support the national COVID-19 response.

"It's extremely important for our active-duty and civilian work force that live and work on the installation to take part in the vaccination," said Navy Master Chief Eric Hubert, command master chief, NAF El Centro. "This is one-step closer for us to help in the fight against the COVID pandemic and keep our Navy force strong."

The distribution of the COVID-19 vaccine follows protocols established by prior influenza vaccine seasons. The administration of the vaccine is coordinated by military medical treatment facilities (MTFs) and all supported Navy units, including NAF El Centro, to ensure operational readiness is maintained and the vaccine is administered when available.

"NAF El Centro was fortunate to receive an allotment of vaccine to cover all eligible volunteers," said Navy Lt. Nicholas Blonien, flight surgeon, NAF El Centro. "Thanks to the education efforts of base leadership and a well-trained vaccination team traveling from San Diego’s Naval Medical Center, we capitalized on the opportunity and delivered first-shots to the majority of the qualified NAFEC workforce. This is the first step in achieving community immunity and bringing an end to this pandemic. I am very thankful to all those who volunteered, and we'll continue to encourage vaccination for anyone who remains hesitant."

The COVID-19 vaccine was developed in approximately 1-year and many have their doubts about its safety and effectiveness. However, Navy Hospital Corpsman 2nd Class Juan Gonzales, assigned to Naval Medical Center San Diego, urges those with concerns, speak with their primary health-care provider.

"I'm glad to see many shipmates and select DOD workers participating in today’s vaccine evolution," Gonzales said. "Like me, they feel fortunate to receive the vaccine. They're taking the right steps to control the virus, helping to reduce the stigma associated with the vaccine and doing their part to keep the community safe."

As NAF El Centro receives the vaccine, masks and physical distancing will still be required until the vaccine is proven to provide long-term protection. Global and national public health authorities are expected to continue to recommend wearing masks and practicing physical distancing, for everyone, until pandemic risk of COVID-19 is substantially reduced.

The mission of NAF El Centro is to support the combat training and readiness of the warfighter. This includes air operations support to operational fleet and training squadrons as well as squadrons from other services (Marine Corps, Army, Air Force) and international military partners.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus
Showing results 1 - 10 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.